Measuring Depth of Invasion in Early Squamous Cell Carcinoma of the Oral Tongue: Positive Deep Margin, Extratumoral Perineural Invasion, and Other Challenges.


Journal

Head and neck pathology
ISSN: 1936-0568
Titre abrégé: Head Neck Pathol
Pays: United States
ID NLM: 101304010

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 10 03 2018
accepted: 23 04 2018
pubmed: 28 4 2018
medline: 18 12 2019
entrez: 28 4 2018
Statut: ppublish

Résumé

The 8th edition of American Joint Committee on Cancer (AJCC 8th) staging manual incorporated depth of invasion (DOI) into pT stage of oral cavity cancer. The aim of this study was to characterize several histological findings that may complicate measurement of DOI in early conventional squamous cell carcinomas (SCC) of the oral tongue: (1) lack of or minimal residual carcinoma following biopsy; (2) positive deep margin; (3) extratumoral perineural invasion (PNI); and (4) lymphatic or vascular invasion. Conventional SCC of the oral tongue (n = 407) with the largest dimension of ≤ 4 cm and with a negative elective cervical lymph node dissection (pN0) were reviewed. A clear plastic ruler was used to measure DOI by dropping a "plumb line" to the deepest point of the invasive tumor from the level of the basement membrane of the normal mucosa closest to the invasive tumor. Examples of identifying  reference point on the mucosal surface of oral tongue from which to measure the DOI are illustrated. In the experience of one contributing institution, the residual carcinoma was absent in 14.2% of glossectomies (34/239), while in 4.8% of cases (10/205) there was only minimal residual carcinoma. In 11.5% (21/183) of pT2 cases the deep margin was positive and thus DOI and pT may be underestimated. Of all cases with PNI, extratumoral PNI was identified in 23.1% (31/134) of cases, but represented the deepest point of invasion in only two cases. In one case, lymphatic invasion represented the deepest point of invasion and could have led to upstaging from pT1 to pT2. In conclusion, DOI measurement for SCC of the oral tongue may require re-examination of the diagnostic biopsy in up to 20% of cases due to the absence or only minimal residual carcinoma in glossectomy specimens. In 11.5% of apparently pT2 cases, DOI may be underestimated due to the positive deep margin. Rarely, extratumoral PNI or lymphatic invasion may be the deepest point of invasion. Overall, two issues (absent or minimal residual disease and positive deep margin) may confound DOI measurement in early SCCs of oral tongue.

Identifiants

pubmed: 29700721
doi: 10.1007/s12105-018-0925-3
pii: 10.1007/s12105-018-0925-3
pmc: PMC6514023
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

154-161

Références

Oral Oncol. 2000 Nov;36(6):508-14
pubmed: 11036243
Am J Surg. 2000 Aug;180(2):139-43
pubmed: 11044531
Cancer. 2009 Apr 1;115(7):1489-97
pubmed: 19197973
Radiat Oncol. 2010 May 27;5:43
pubmed: 20504371
Am J Otolaryngol. 2012 Mar-Apr;33(2):212-5
pubmed: 22177613
Cancer. 2013 Mar 15;119(6):1168-76
pubmed: 23184439
J Oral Maxillofac Surg. 2013 Apr;71(4):775-85
pubmed: 23265849
Oral Oncol. 2013 Nov;49(11):1077-82
pubmed: 23988568
JAMA Otolaryngol Head Neck Surg. 2014 Dec;140(12):1138-48
pubmed: 25075712
JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1104-10
pubmed: 26225798
CA Cancer J Clin. 2017 Mar;67(2):122-137
pubmed: 28128848
Oral Oncol. 2017 Dec;75:184-188
pubmed: 29074194
Oral Oncol. 2017 Nov;74:30-33
pubmed: 29103748
Oral Oncol. 2018 Feb;77:29-36
pubmed: 29362123

Auteurs

Jeremie Berdugo (J)

Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Lester D R Thompson (LDR)

Department of Pathology, Southern California Permanente Medical Group, Woodland Hills, CA, USA.

Bibianna Purgina (B)

Department of Pathology and Laboratory Medicine, The Ottawa Hospital/University of Ottawa, Ottawa, ON, Canada.

Charles D Sturgis (CD)

Cleveland Clinic, Cleveland, OH, USA.

Madalina Tuluc (M)

Thomas Jefferson University, Philadelphia, PA, USA.

Raja Seethala (R)

Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Simion I Chiosea (SI)

Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. chioseasi@upmc.edu.
Presbyterian University Hospital, A610.3, 200 Lothrop St., Pittsburgh, PA, 15213, USA. chioseasi@upmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH